lets not forget that these guys are the recipients of non dilutive cash advances also. A traditional cap raise is far from certain. The costs of running the trials are just what they are, expensive. Nothing can change that.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $735.5M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 60.3¢ | 58.5¢ | $370.2K | 620.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 75636 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 30456 | 19 |
View Market Depth
| Last trade - 12.22pm 12/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |